Global Veterinary Medicine Market By Animal Type (Livestock Animals, Companion Animals), By Product (Biologics, Pharmaceuticals) By Route of Administration (Oral, Injectable, Topical, Other Routes), By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Offline Retail Stores, Others) And By Geography – Market Analysis, Opportunities, Trends And Forecast From 2023 to 2035
The Global Veterinary Medicine Market was valued at $47.35 Billion in 2024 and is anticipated to grow at a CAGR of 8.05% from 2025 to 2035. This growth is attributed to several macro and microeconomic factors such as
Increasing Pet Ownership and Humanization of Pets
The increasing trend of pet ownership, coupled with the growing humanization of pets, is a significant driving factor fueling the expansion of the global veterinary medicine market. As more households welcome companion animals into their families, the perception of pets is evolving from mere property to cherished family members. This shift in perspective leads to a greater willingness among pet owners to invest in their animals' health and well-being, seeking high-quality medical care, preventative treatments, and advanced veterinary services. The humanization trend also drives the demand for pet healthcare options that mirror those available for humans, including specialized diets, advanced diagnostics, and sophisticated surgical procedures. Furthermore, increased awareness of pet health issues and the availability of more information empower pet owners to be proactive in seeking veterinary care. This growing commitment to pet health and welfare directly translates to a higher demand for a wide range of veterinary pharmaceuticals, vaccines, diagnostics, and other medical products, thereby propelling the growth of the global veterinary medicine market.
Further several factors restraining the market growth include
Regulatory Challenges and Stringent Approval Processes
A notable restraining factor influencing the global veterinary medicine market is the presence of complex regulatory challenges and stringent approval processes for new animal health products. The development and commercialization of veterinary pharmaceuticals, vaccines, and diagnostics are subject to rigorous evaluation by regulatory authorities worldwide to ensure their safety, efficacy, and quality for animal use and, in some cases, for human food safety. These approval processes often involve extensive preclinical and clinical trials, detailed documentation, and lengthy review periods, which can significantly increase the time and cost associated with bringing new veterinary medicines to market. Varying regulatory requirements across different regions and countries further complicate the process for global manufacturers seeking to introduce their products internationally. These hurdles can particularly impact smaller companies with limited resources and may slow down the availability of innovative veterinary treatments, ultimately restraining the overall growth and accessibility within the global veterinary medicine market.
The growth of preventive healthcare and vaccines in veterinary medicine and collaborations and alliances in the Veterinary Medicine market are expected to generate higher avenues during the forecast period.
In the wake of the COVID-19 pandemic, supply chain disruptions have led to supply shortages or lower demand in the Veterinary Medicine market. The pandemic has caused a decline in new orders and a corresponding decrease in Animal Typeion.
This section will analyze how COVID-19 has impacted supply chains, leading to shortages and lower demand for Veterinary Medicine.
In terms of COVID-19 impact, the Veterinary Medicine market report also includes the following data points:
Impact on Veterinary Medicine market size
Operating Weights Trend, Preferences, and Budget Impact
Regulatory Framework/Outdoor Policies
Key Players' Strategy to Tackle Negative Impact/Post-COVID Strategies
Opportunity in the Veterinary Medicine market
Key Insight in the report:
The global Veterinary Medicine market report covers an executive summary, market dynamics, COVID impact & post-COVID scenario, market size and forecast, competitive intelligence, market positioning, and Distribution Channels.
Our report covers extensive competitive intelligence which includes the following data points:
Business Overview
Business Segment Data
Financial Data
Animal Type Segment Analysis and Specification
Recent Development and Company Strategy Analysis
SWOT Analysis
Veterinary Medicine Market Segmentation:
Animal Type
Livestock Animals
Companion Animals
Product
Biologics
Pharmaceuticals
Route of Administration
Oral
Injectable
Topical
Other Routes
Distribution Channel
Veterinary Hospitals & Clinics
E-commerce
Offline Retail Stores
Others
Region/ Countries Covered:
North America
US
Canada
Mexico
Europe
U.K.
Germany
BeNeLux
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
Japan
Australia
India
South Korea
Thailand
Rest of Asia Pacific
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
UAE
Egypt
South Africa
Rest of Middle East & Africa
Key Players Analyzed in the Report:
Zoetis Inc.
Boehringer Ingelheim International GmbH
Merck & Co., Inc
Elanco
Dechra Pharmaceuticals PLC
Ceva Santé Animale
Phibro Animal Health Corporation
Virbac
Bimeda
Biogénesis Bagó
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook